MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Option Exercise | A | 2.04 | 80,000 | 163,200 | 80,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Resnick Paul F | VICE PRESIDENT, CBO | Option Exercise | A | 2.04 | 80,000 | 163,200 | 80,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | EXECUTIVE VICE PRES ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.04 | 195,000 | 397,800 | 195,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | A | 2.04 | 290,000 | 591,600 | 290,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | A | 2.04 | 290,000 | 591,600 | 290,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Varvaro Thomas C | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | EISENBERG JEFFREY F | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | ||
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | |
| Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | CHIEF SCIENCE OFFIC ... | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 |